Yakobson, A.; Agbarya, A.; Dudnik, Y.; Gothelf, I.; Miari, A.; Brenner, R.; Abu Jama, A.; Abu Yasin, N.; Dabah, A.E.N.; Meirovitz, A.;
et al. Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients. Int. J. Mol. Sci. 2026, 27, 1541.
https://doi.org/10.3390/ijms27031541
AMA Style
Yakobson A, Agbarya A, Dudnik Y, Gothelf I, Miari A, Brenner R, Abu Jama A, Abu Yasin N, Dabah AEN, Meirovitz A,
et al. Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients. International Journal of Molecular Sciences. 2026; 27(3):1541.
https://doi.org/10.3390/ijms27031541
Chicago/Turabian Style
Yakobson, Alexander, Abed Agbarya, Yulia Dudnik, Itamar Gothelf, Asmah Miari, Ronen Brenner, Ashraf Abu Jama, Nashat Abu Yasin, Abd El Nazer Dabah, Amichay Meirovitz,
and et al. 2026. "Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients" International Journal of Molecular Sciences 27, no. 3: 1541.
https://doi.org/10.3390/ijms27031541
APA Style
Yakobson, A., Agbarya, A., Dudnik, Y., Gothelf, I., Miari, A., Brenner, R., Abu Jama, A., Abu Yasin, N., Dabah, A. E. N., Meirovitz, A., Maimon Rabinovich, N., & Shalata, W.
(2026). Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients. International Journal of Molecular Sciences, 27(3), 1541.
https://doi.org/10.3390/ijms27031541